Criteria

MDS-PSP criteria[3]

The Movement Disorder Society (MDS) criteria, published in 2017, aim to optimise the sensitivity and specificity of progressive supranuclear palsy (PSP) diagnosis, regardless of the phenotypic subtype.[3]​ A summary of the key elements is included here.

Mandatory inclusion criteria
  1. Sporadic occurrence

  2. Age 40 years or older at onset of first PSP-related symptom

  3. Gradual progression of PSP-related symptoms

There are also multiple mandatory exclusion criteria aimed at ruling out other differential diagnoses that can present in a similar way to PSP.

Four functional domains

These summarise the characteristic manifestations of PSP, with three typical clinical features listed under each domain. The level of certainty for the diagnosis is highest for feature 1, intermediate for feature 2, and lowest for feature 3 in each domain.

Ocular motor dysfunction

  • O1: Vertical supranuclear gaze palsy

  • O2: Slow velocity of vertical saccades

  • O3: Frequent macro square wave jerks or 'eyelid-opening apraxia'

Postural instability

  • P1: Repeated unprovoked falls within the first 3 years

  • P2: Tendency to fall on the pull-test within the first 3 years

  • P3: More than two steps backwards on the pull-test within the first 3 years

Akinesia

  • A1: Progressive gait freezing within the first 3 years

  • A2: Parkinsonism, akinetic-rigid, predominantly axial, and levodopa-resistant

  • A3: Parkinsonism, with tremor and/or asymmetric and/or levodopa-responsive

Cognitive dysfunction

  • C1: Speech/language disorder (i.e., non-fluent/agrammatic variant of primary progressive aphasia or progressive apraxia of speech)

  • C2: Frontal cognitive/behavioural presentation

  • C3: Corticobasal syndrome

Degree of diagnostic certainty

The patient can then be diagnosed with probable PSP, possible PSP, or suggestive of PSP depending on the combination of clinical features, as follows:

Probable PSP:

  • PSP-RS: (O1 or O2) + (P1 or P2)

  • PSP-PGF: (O1 or O2) + A1

  • PSP-P: (O1 or O2) + (A2 or A3)

  • PSP-F: (O1 or O2) + C2

Possible PSP:

  • PSP-OM: O1

  • PSP-RS: O2 + P3

  • PSP-PGF: A1

  • PSP-SL: (O1 or O2) + C1

  • PSP-CBS: (O1 or O2) + C3

Suggestive of PSP:

  • PSP-OM: O2 or O3

  • PSP-PI: P1 or P2

  • PSP-RS: O3 + (P2 or P3)

  • PSP-P: (A2 or A3) + (O3, P1, P2, C1, C2, CC1, CC2, CC3, or CC4)

  • PSP-SL: C1

  • PSP-CBS: C3

Key:

PSP-RS: PSP Richardson's syndrome

PSP-PGF: PSP with progressive gait freezing

PSP-P: PSP-parkinsonism

PSP-F: PSP-frontal presentation

PSP-OM: PSP-oculomotor dysfunction

PSP-SL: PSP-speech/language disorder

PSP-CBS: PSP-corticobasal syndrome

PSP-PI: PSP-postural instability

Supportive features

The following can increase diagnostic confidence but do not qualify as diagnostic criteria.

Clinical clues:

  • Levodopa resistance

  • Hypokinetic, spastic dysarthria

  • Dysphagia

  • Photophobia

Imaging findings:

  • Predominant midbrain atrophy or hypometabolism

  • Postsynaptic striatal dopaminergic degeneration

NINDS-SPSP[28]

​The National Institute of Neurological Disorders and Stroke/Society for PSP (NINDS/SPSP) criteria, published in 1996, specified three degrees of diagnostic certainty for PSP: possible PSP, probable PSP, and definite PSP.[28] The criteria have excellent specificity for PSP but are poorly sensitive for the non-Richardson’s syndrome phenotypes of the condition and hence have been superseded in clinical practice by the 2017 MDS criteria.[3]

Possible PSP

Gradually progressive disorder with onset at age 40 years or later and either one of the below present (with no alternative explanation):

  1. Vertical supranuclear gaze palsy, or

  2. Postural instability with falls within the first year of onset together with slowing of vertical saccades

Probable PSP

​Gradually progressive disorder with onset at age 40 or later with both of the below present (and no alternative explanation):

  1. Vertical supranuclear gaze palsy, and

  2. Postural instability with falls within the first year

Definite PSP

Clinically probable or possible PSP together with postmortem histopathological evidence of typical PSP.

Use of this content is subject to our disclaimer